Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01745588. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of High Dose Melphalan to Treat Multiple Myeloma
ClinicalTrials.gov study NCT01572688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07100067. IPD Sharing: NO. Countries: 1. Publications: 0.
Back Pain Prevention in Multiple Myeloma Using an External Spinal Brace
ClinicalTrials.gov study NCT02898064. IPD Sharing: NO. Countries: 1. Publications: 0.
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
ClinicalTrials.gov study NCT06207799. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov study NCT05893693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)
ClinicalTrials.gov study NCT04184050. IPD Sharing: YES. Countries: 3. Publications: 0.
Study of XL999 in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00304590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05177536. IPD Sharing: NO. Countries: 1. Publications: 0.
Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06304636. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.
ClinicalTrials.gov study NCT00200668. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT07018050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With
ClinicalTrials.gov study NCT04045028. IPD Sharing: YES. Countries: 2. Publications: 0.
Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant
ClinicalTrials.gov study NCT03015792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00045136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06296121. IPD Sharing: NO. Countries: 1. Publications: 0.
Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.
ClinicalTrials.gov study NCT05835726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients
ClinicalTrials.gov study NCT02471820. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT01801436. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
ClinicalTrials.gov study NCT00388999. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.